PMS Pregabalin Capsule 150 mg

Adult dose

This drug is administered orally in two divided doses daily, regardless of food. 1. Neuropathic pain 1) Peripheral neuropathic pain - Starting dose: 150 mg once daily - Can be increased to 300 mg daily within 3 to 7 days - May be further increased to a maximum of 600 mg daily at intervals of 7 days 2) Central neuropathic pain - Starting dose: 150 mg once daily - After one week, 300 mg daily can be considered

Child dose

The safety and efficacy data are insufficient for children under 12 years of age and adolescents aged 12-17, so administration is not recommended.

This medication may increase the risk of suicidal thoughts or behaviors, so mood changes or abnormal behavior signs should be closely monitored during treatment. It should not be taken by those allergic to its ingredients, and patients with certain genetic metabolic disorders should avoid it. Diabetic patients may need to adjust the dosage of their blood glucose medications due to weight gain after taking this drug. If severe allergic reactions such as angioedema occur, use should be discontinued immediately, and medical advice should be sought. Elderly patients should be cautious as there is a risk of falls or injuries due to dizziness or drowsiness from this medication. Blurry vision or changes in vision may occur; if these symptoms arise, the medication should be discontinued and a doctor consulted. Abrupt discontinuation of this drug can result in withdrawal symptoms such as insomnia, headache, and anxiety, so the dosage should be gradually reduced according to a doctor's instructions. There is a risk of drug abuse; therefore, patients with a history of substance abuse should use it with caution. Patients with impaired kidney function should have their dosage adjusted, and those with heart failure should use it carefully. When used in combination with other drugs that have central nervous system depressant effects, there is an increased risk of respiratory depression, so caution is advised. Pregnant women should avoid use in early pregnancy to reduce the risk of fetal malformations, and women of childbearing age should use effective contraception. Breastfeeding women are advised to discontinue either breastfeeding or the medication since it may be transferred through breast milk. Activities requiring concentration, such as driving or operating machinery, should be avoided until dizziness or drowsiness has completely resolved after taking this medication. In case of overdose, symptoms such as confusion, drowsiness, and seizures may occur, and immediate medical treatment is required. This medication should be kept out of the reach of children and not transferred to other containers for safety.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in the mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, breathing abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headaches, thunderclap headaches, seizures, altered consciousness, visual disturbances, paralysis, urinary symptoms

Mild side effects

• Dizziness
• drowsiness
• confusion
• disorientation
• irritability
• depression
• euphoric feelings
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly closed container to protect it from air and moisture, and maintaining a temperature between 15 and 30 degrees Celsius at room temperature is recommended. This storage method helps preserve the drug's effectiveness for a longer period.

Appearance

Hard capsule with a white upper part and a white lower part containing white or light yellow powder

Package unit

30 capsules/bottle, 100 capsules/bottle